FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2527988385> ?p ?o ?g. }

• W2527988385 endingPage "611" @default.
• W2527988385 startingPage "611" @default.
• W2527988385 abstract "Multiple myeloma (MM) is a clonal B-cell malignancy characterized by an accumulation of clonal plasma cells (PC) in the bone marrow (BM) leading to bone destruction and BM failure. Despite recent advances in pharmacological therapy, MM remains a largely incurable pathology. Therefore, novel effective and less toxic agents are urgently necessary. In the last few years, pomegranate has been studied for its potential therapeutic properties including treatment and prevention of cancer. Pomegranate juice (PGJ) contains a number of potential active compounds including organic acids, vitamins, sugars, and phenolic components that are all responsible of the pro-apoptotic effects observed in tumor cell line. The aim of present investigation is to assess the antiproliferative and antiangiogenic potential of the PGJ in human multiple myeloma cell lines. Our data demonstrate the anti-proliferative potential of PGJ in MM cells; its ability to induce G0/G1 cell cycle block and its anti-angiogenic effects. Interestingly, sequential combination of bortezomib/PGJ improved the cytotoxic effect of the proteosome inhibitor. We investigated the effect of PGJ on angiogenesis and cell migration/invasion. Interestingly, we observed an inhibitory effect on the tube formation, microvessel outgrowth aorting ring and decreased cell migration and invasion as showed by wound-healing and transwell assays, respectively. Analysis of angiogenic genes expression in endothelial cells confirmed the anti-angiogenic properties of pomegranate. Therefore, PGJ administration could represent a good tool in order to identify novel therapeutic strategies for MM treatment, exploiting its anti-proliferative and anti-angiogenic effects. Finally, the present research supports the evidence that PGJ could play a key role of a future therapeutic approach for treatment of MM in order to optimize the pharmacological effect of bortezomib, especially as adjuvant after treatment." @default.
• W2527988385 created "2016-10-14" @default.
• W2527988385 creator A5010014894 @default.
• W2527988385 creator A5010348062 @default.
• W2527988385 creator A5018769545 @default.
• W2527988385 creator A5024001615 @default.
• W2527988385 creator A5027502879 @default.
• W2527988385 creator A5056665120 @default.
• W2527988385 creator A5057977071 @default.
• W2527988385 creator A5062095563 @default.
• W2527988385 creator A5062765629 @default.
• W2527988385 creator A5064782017 @default.
• W2527988385 creator A5065763544 @default.
• W2527988385 creator A5065852754 @default.
• W2527988385 creator A5070046619 @default.
• W2527988385 creator A5070950184 @default.
• W2527988385 creator A5072417532 @default.
• W2527988385 creator A5074421892 @default.
• W2527988385 date "2016-10-01" @default.
• W2527988385 modified "2023-10-18" @default.
• W2527988385 title "Antiproliferative and Antiangiogenic Effects of Punica granatum Juice (PGJ) in Multiple Myeloma (MM)" @default.
• W2527988385 cites W1516746818 @default.
• W2527988385 cites W1601856726 @default.
• W2527988385 cites W1909967580 @default.
• W2527988385 cites W1966163309 @default.
• W2527988385 cites W1966903210 @default.
• W2527988385 cites W1970525158 @default.
• W2527988385 cites W1971240424 @default.
• W2527988385 cites W1974822060 @default.
• W2527988385 cites W1976108371 @default.
• W2527988385 cites W1978470743 @default.
• W2527988385 cites W1988315385 @default.
• W2527988385 cites W1990260803 @default.
• W2527988385 cites W2002264579 @default.
• W2527988385 cites W2018555744 @default.
• W2527988385 cites W2022300670 @default.
• W2527988385 cites W2022532937 @default.
• W2527988385 cites W2027337327 @default.
• W2527988385 cites W2028808625 @default.
• W2527988385 cites W2031220614 @default.
• W2527988385 cites W2037007921 @default.
• W2527988385 cites W2038544675 @default.
• W2527988385 cites W2040838250 @default.
• W2527988385 cites W2055125344 @default.
• W2527988385 cites W2062946794 @default.
• W2527988385 cites W2067132771 @default.
• W2527988385 cites W2068548764 @default.
• W2527988385 cites W2073911274 @default.
• W2527988385 cites W2077966345 @default.
• W2527988385 cites W2080635229 @default.
• W2527988385 cites W2089425453 @default.
• W2527988385 cites W2090286010 @default.
• W2527988385 cites W2092252601 @default.
• W2527988385 cites W2093285753 @default.
• W2527988385 cites W2095931589 @default.
• W2527988385 cites W2104477238 @default.
• W2527988385 cites W2104856353 @default.
• W2527988385 cites W2107283374 @default.
• W2527988385 cites W2107880533 @default.
• W2527988385 cites W2119944195 @default.
• W2527988385 cites W2120529614 @default.
• W2527988385 cites W2123712628 @default.
• W2527988385 cites W2128038298 @default.
• W2527988385 cites W2131660697 @default.
• W2527988385 cites W2136347443 @default.
• W2527988385 cites W2146166890 @default.
• W2527988385 cites W2150099109 @default.
• W2527988385 cites W2151135547 @default.
• W2527988385 cites W2153616582 @default.
• W2527988385 cites W2154061517 @default.
• W2527988385 cites W2168249779 @default.
• W2527988385 cites W2172066048 @default.
• W2527988385 cites W2183961304 @default.
• W2527988385 cites W2192526455 @default.
• W2527988385 cites W2198388098 @default.
• W2527988385 cites W2289965873 @default.
• W2527988385 cites W2295129153 @default.
• W2527988385 cites W235678687 @default.
• W2527988385 doi "https://doi.org/10.3390/nu8100611" @default.
• W2527988385 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5083999" @default.
• W2527988385 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27706074" @default.
• W2527988385 hasPublicationYear "2016" @default.
• W2527988385 type Work @default.
• W2527988385 sameAs 2527988385 @default.
• W2527988385 citedByCount "30" @default.
• W2527988385 countsByYear W25279883852017 @default.
• W2527988385 countsByYear W25279883852018 @default.
• W2527988385 countsByYear W25279883852019 @default.
• W2527988385 countsByYear W25279883852020 @default.
• W2527988385 countsByYear W25279883852021 @default.
• W2527988385 countsByYear W25279883852022 @default.
• W2527988385 countsByYear W25279883852023 @default.
• W2527988385 crossrefType "journal-article" @default.
• W2527988385 hasAuthorship W2527988385A5010014894 @default.
• W2527988385 hasAuthorship W2527988385A5010348062 @default.
• W2527988385 hasAuthorship W2527988385A5018769545 @default.
• W2527988385 hasAuthorship W2527988385A5024001615 @default.
• W2527988385 hasAuthorship W2527988385A5027502879 @default.

• next